Global Comprehensive Metabolic Panel Cmp Testing Market Growth Analysis 2024, Forecast To 2033
8 Mar, 2024
The comprehensive metabolic panel (CMP) testing market has witnessed strong growth, expanding from $15.61 billion in 2023 to $16.94 billion in 2024, with a CAGR of 8.5%. This growth is driven by the increase in chronic diseases and the healthcare system's emphasis on preventive care. Projections suggest further growth to $23.28 billion in 2028, with a CAGR of 8.3%, fueled by personalized medicine initiatives and the integration of CMP testing into telehealth services.
Global Comprehensive Metabolic Panel CMP Testing Market Key Driver
The comprehensive metabolic panel (CMP) testing market is poised for growth driven by the increasing prevalence of cardiovascular diseases and diabetes globally. Cardiovascular disorders and diabetes are significant health concerns, necessitating accurate diagnosis and monitoring through blood tests such as the CMP. With an increase in doctor-certified fatalities attributable to coronary heart disease and a rising prevalence of diabetes worldwide, as reported by the Australian Institute of Health and Welfare and the International Diabetes Federation, respectively, the demand for CMP testing is expected to rise, driven by the imperative to address these prevalent health conditions.
Get A Free Sample Of The Global Comprehensive Metabolic Panel CMP Testing Market ReportGlobal Comprehensive Metabolic Panel CMP Testing Market Segments
The comprehensive metabolic panel (cmp) testing market covered in this report is segmented –
1) Disease:Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) Test Type:Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) End User:Laboratories, Point Of Care (PoC)
By Geography: The countries covered in the comprehensive metabolic panel (cmp) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Comprehensive Metabolic Panel CMP Testing Industry Players
F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Siemens Healthineers AG; Mayo Clinic; Laboratory Corporation of America Holdings; Mercy; Mount Sinai Health System; Quest Diagnostics Incorporated; Sonic Healthcare Limited; Hologic Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Werfen SA; DiaSorin S.p.A.; Randox Laboratories Ltd.; ARUP Laboratories Inc.; Invitae Corporation; Abaxis Inc.; Metropolis Healthcare Limited; Clinical Reference Laboratory (CRL); Centogene AG; Spectra Laboratories; Unipath Systems Ltd.; Scion Lab Services LLC; Weldon Biotech Pvt Ltd.; Corona Pathology;Ulta Lab Tests LLC; Any Lab Test Now; Applied InGENuity Diagnostics LLC; Walk-In Lab LLC.
Get The Full Global Comprehensive Metabolic Panel CMP Testing Market Report
Comprehensive Metabolic Panel CMP Testing Market Overview
A comprehensive metabolic panel (CMP) test is a blood test containing 14 separate parameters that offer crucial knowledge about the body's chemical equilibrium and metabolism. It is frequently used to assess nutritional levels, liver and kidney function, and diagnosis, screening, and monitoring.